-
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.
-
Elevated high-sensitivity C-reactive protein (CRP) may help identify otherwise healthy patients with normal cholesterol levels who will benefit from statin therapy, according to the JUPITER trial published in November.
-
The American College of Physicians has issued a practice guideline for the use of antidepressants to treat depressive disorders.
-
The continued shortage of the Haemophilus influenza type b (Hib) vaccine has not led to an increase in Haemophilus infections according to the MMWR.
-
The FDA has approved fesoterodine fumarate for the treatment of overactive bladder.
-
When it comes to current methods of delivery of hormonal contraception, women now can choose among pill, patch, ring, implant, and intrauterine forms of birth control.
-
Results from a just-published study indicate that teens who are treated for pelvic inflammatory disease (PID) are at risk for subsequent sexually transmitted infections (STIs) and/or PID for 48 months.1 What can clinicians do to stem subsequent infection?
-
Good news: About 75% of respondents to the 2008 Contraceptive Technology Update Salary Survey say they received increases in their paychecks in the last year. Bad news: The majority (57%) saw only a 1%-3% increase.
-
Results from a Phase III study in men ages 16 to 26 indicate that the human papillomavirus (HPV) vaccine Gardasil (Merck & Co.) prevented 90% of external genital lesions caused by types 6, 11, 16, and 18 of HPV.
-
How many of your patients rely on vasectomy for contraception? About 500,000 vasectomies are performed each year in the United States; about one out of six U.S. men over age 35 has been vasectomized, with prevalence increasing with education and income.
